On four occasions, four horses with heaves and four horses with small airway inflammatory diseases inhaled 0.9% saline based aerosol mixtures with or without lipopolysaccharides (LPS). Prior to the first saline and LPS inhalation, horses were untreated, while three and a half days prior to the third and forth inhalation horses had received 0.8 μ g/kg clenbuterol intravenously twice daily.
The messenger RNA (mRNA) expression of tumour necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-4, IL-6, IL-8, IL-10 and interferon- γ (IFN- γ) was investigated by RT-PCR, all of which were expressed in the white blood cells of samples collected.
Inhalation of LPS only changed the cytokine expression profile of IL-10, IL-4 and TNF-α mRNA which were higher after challenge with LPS. However in those horses that were treated with clenbuterol the LPS-induced IL-10 mRNA expression was shown to be suppressed. Further changes in IL-4 and TNF-α were not significant. Thus the results of this study indicated that clenbuterol can modulate the expression of IL-10 mRNA in peripheral white blood cells in those horses with small airway diseases that have been exposed to LPS.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bull, S., Laan, T., de Vrieze, G., Spee, B., van den Hoven, R. and Fink-Gremmels, J., 2003. Modulation of LPS—induced cytokine production by clenbuterol in equine macrophages Journal of Veterinary Pharmacology and Therapeutics, 26(suppl.1) Proceedings of the 9th International Congress of the EAVPT, 234
Colahan, P.T., Kollias-Bakert, C., Leutenegger, C.M. and Jones, J.H., 2002. Does training affect mRNA transcription for cytokine production in circulating leucocytes? Equine Veterinary Journal, (Supplement), 34, 154–158
Fogelmark, B., Yuasa, K. and Rylander, R., 1992. Acute pulmonary toxicity of inhaled beta—1 3 glucan and endotoxin, Agents And Actions, 35, 50–56
Giguère, S., Viel, L. Lee, E., MacKay, R.J., Hernandez, J., Franchini, M., 2002. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology, 85, 147–158
Hoffman, A.M., 1999. Bronchoalveolar lavage technique and cytological diagnosis of small airway inflammatory disease. Equine Veterinary Education, 11, 330–336
Izeboud, C.A., Mocking, J.A., Monshouwer, M., van Miert, A.S.J.P.A.M. and Witkamp, R.F., 1999. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. Journal of Receptor and Signal Transduction Research, 19, 191–202
Joubert, P., Silversides, D.W. and Lavoie, J.-P., 2001. Equine neutrophils express mRNA for tumor necrosis factor, interleukin (IL)-1β, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-γ. Equine Veterinary Journal, 33, 730–733
Lavoie, J. P., Maghni, K., Desnoyers, M., Taha, R., Martin, J.G. and Hamid, Q.A., 2001. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine, 164, 1410–1413
Lim, W.-S., Edwards, J.F., Boyd, N.K., Payne, S.L., and Ball, J.M., 2003. Simultaneous quantitation of equine cytokine mRNAs using a multi-probe ribonuclease protection assay. Veterinary Immunology and Immunopathology, 91, 45–51
Mair, T.S. and Derksen, F.J. 2000. Chronic obstructive pulmonary disease: a review. Equine Veterinary Education 12, 35–44
Pedersen, L.G., Castelruiz, Y., Jacobsen, S. and Aasted, B., 2002. Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Veterinary Immunology and Immunopathology, 88, 111–122
Pirie, R.S., Dixon, P.M., Collie, D.D.S. and McGorum, B.C., 2001. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Veterinary Journal, 33, 311–318
Sasse, H.L. and Hajer, R., 1978. NAB 365, a beta2-receptor sympathomimetic agent: clinical experience in horses with lung disease. Journal of Veterinary Pharmacology and Therapeutics, 1, 241–244
Stadler, P. and Deegen, E., 1986. Diurnal variation of dynamic compliance, resistance and viscous work of breathing in normal horses and horses with lung disorders. Equine Veterinary Journal, 18, 171–178
Swiderski, C.E., Klei, T.R. and Horohov, D.W., 1999. Quantitative measurement of equine cytokine mRNA expression by polymerase chain reaction using target-specific standard curves. Journal of Immunological Methods, 222, 155–169
Van den Hoven, R., Duvigeau, J. C., Hartl, R.T., Riedelberger, K., Teinfalt, M. and Gemeiner, M., 2004. The expression of mRNA for tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, IL-10, tissue growth factor—β and interferon-γ in BALF cells from horses challenged with LPS and treated with clenbuterol. Journal of Equine Veterinary Science, 24, 29–36
Van Miert, A.S.J.P.A.M., 2002. Present concepts on the inflammatory modulators with special reference to cytokines. Veterinary Research Communications, 26, 111–126
van den Hoven, R., Duvigneau, J.C., Hartl, R.T. and Gemeiner, M., 2006. Clenbuterol affects the expression of messenger RNA for interleukin 10 in peripheral leukocytes from horses challenged intrabronchially with lipopolysaccharides. Veterinary Research Communications, 30(8), 921–928
About this article
Cite this article
van den Hoven, R., Duvigneau, J.C., Hartl, R.T. et al. Clenbuterol Affects the Expression of Messenger RNA for Interleukin 10 in Peripheral Leukocytes from Horses Challenged Intrabronchially with Lipopolysaccharides. Vet Res Commun 30, 921–928 (2006). https://doi.org/10.1007/s11259-006-3383-4
- interleukin 10
- recurrent airway obstruction